Stock Events

Stock Events

JanOne

€0.4778

0

+€0.00+0% 19:56 Today

Statistics

Day High

0.48

Day Low

0.4702

52W High

0.48

52W Low

0.4702

Volume

2,000

Avg. Volume

-

Mkt Cap

101.4M

P/E Ratio

-

Dividend Yield

-

Dividend

-

Upcoming

Earnings

6AugExpected

Q1 2026

Next

-0.13

-0.13

-0.12

-0.12

Expected EPS

-0.1313325

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 5AR.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Pfizer is a global pharmaceutical company that competes with JanOne in the development of treatments for various diseases, including those JanOne targets with its non-opioid pain management solutions.

Johnson & Johnson

Johnson & Johnson, through its pharmaceutical segment, competes in developing medications and treatments that can overlap with JanOne's focus areas, including pain management.

AbbVie operates in the pharmaceuticals sector, focusing on innovative therapies, directly competing with JanOne in areas like chronic pain treatment.

Merck is involved in the development and manufacturing of drugs that address serious health issues, competing with JanOne in the pharmaceutical space, especially in pain management solutions.

Teva- Pharmaceutical Industries

Teva Pharmaceutical Industries specializes in generic and specialty medicines, including pain management, making it a competitor to JanOne in the non-opioid pain relief market.

Novartis is a global healthcare company that produces drugs in various therapeutic areas, including pain, competing with JanOne's mission to offer alternative pain solutions.

Bristol-Myers Squibb

Bristol Myers Squibb is a biopharmaceutical company that develops medicines in several therapeutic areas, potentially competing with JanOne in the area of pain management.

Eli Lilly and Company focuses on pharmaceuticals in areas that could compete with JanOne, especially considering their work on pain and chronic conditions.

GlaxoSmithKline is a healthcare company that produces pharmaceuticals across various areas, including pain relief, making it a competitor to JanOne.

Sanofi is a global life sciences company that offers a broad range of medicines, including those for pain management, competing with JanOne's focus on non-opioid solutions.

Holdings

Regions

Sectors

About

Janus Living, Inc. functions as a specialized real estate investment trust (REIT), concentrating solely on the senior housing sector. Its portfolio encompasses numerous communities situated throughout the United States, each meticulously crafted to provide residents with thoughtfully designed, amenity-rich living spaces. The company was established in December 2025 and operates its main office from Denver, Colorado.

Show more...

CEO

Mr. Scott M. Brinker

Employees

5

Country

United States

ISIN

US47089W1045

Listings

0 Comments

Share your thoughts

FAQ

What is JanOne stock price today?▼

The current price of 5AR.STU is €0.48 EUR — it has increased by +0% in the past 24 hours. Watch JanOne stock price performance more closely on the chart.

What is JanOne stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange JanOne stocks are traded under the ticker 5AR.STU.

What is JanOne market cap?▼

Today JanOne has the market capitalization of 101.4M

When is the next JanOne earnings date?▼

JanOne is going to release the next earnings report on August 06, 2026.

How many employees does JanOne have?▼

As of July 09, 2026, the company has 5 employees.

In which sector is JanOne located?▼

JanOne operates in the Other sector.

When did JanOne complete a stock split?▼

JanOne has not had any recent stock splits.

Where is JanOne headquartered?▼

JanOne is headquartered in Denver, United States.